Bulletin
Investor Alert

New York Markets Close in:

Ionis Pharmaceuticals Inc.

NAS: IONS

GO
/marketstate/country/us

Market open

/zigman2/quotes/201272020/composite

$

62.44

Change

+1.09 +1.77%

Volume

Volume 170,794

Jan 15, 2021, 10:21 a.m.

Real time quotes

/zigman2/quotes/201272020/composite

Previous close

$ 61.35

$ 62.44

Change

+1.09 +1.77%

Day low

Day high

$60.71

$63.19

Open
Open: 61.33

52 week low

52 week high

$39.32

$63.49

Open

Market cap

$8.58B

Average volume

1.17M

P/E ratio

155.32

Rev. per Employee

$1.37M

EPS

0.40

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/ions

MarketWatch News on IONS

  1. Ionis Pharmaceuticals started at hold at Benchmark

    5:41 a.m. Sept. 2, 2020

    - Tomi Kilgore

  2. Panic Takes Hold

    7:39 p.m. March 12, 2020

    - Barron's Online

  3. Ionis Pharmaceuticals started at buy with $70 stock price target at BofA Merrill Lynch

    9:39 a.m. Nov. 13, 2019

    - Tomi Kilgore

  4. Bayer to advance Ionis Pharma's clotting medicine

    6:21 a.m. Oct. 9, 2019

    - MarketWatch.com

  5. How Biotech Is Targeting RNA to Cure Diseases

    7:01 a.m. Sept. 3, 2019

    - Barron's Online

  6. Ionis Pharmaceuticals stock price target raised to $63 vs. $60 at Stifel

    6:28 a.m. May 10, 2019

    - Ciara Linnane

  7. Ionis Pharmaceuticals stock price target raised to $55 from $47 at J.P. Morgan

    8:12 a.m. March 18, 2019

    - Tomi Kilgore

  8. Ionis Pharmaceuticals stock price target raised to $55 from $47 at SVB Leerink

    8:44 a.m. March 15, 2019

    - Tomi Kilgore

  9. Ionis Pharmaceuticals outlines CEO succession plan

    6:39 p.m. Dec. 20, 2018

    - Wallace Witkowski

  10. Ionis Pharmaceuticals started at market perform with $50 stock price target at Leerink

    7:14 a.m. Nov. 29, 2018

    - Tomi Kilgore

  11. Ionis Pharmaceuticals' could receive up to $759 mln from new collaboration with Roche

    8:18 a.m. Oct. 10, 2018

    - Tomi Kilgore

  12. Ionis stock drops 13% as FDA fails to approve key drug

    6:09 a.m. Aug. 29, 2018

    - Emma Court

  13. Akcea, Ionis shares drop after disappointing FDA decision

    4:07 p.m. Aug. 27, 2018

    - Wallace Witkowski

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/ions

Other News on IONS

  1. Pharming Group Lines Up U.S. Offering Plan

    12:47 p.m. Dec. 21, 2020

    - Seeking Alpha

  2. Ionis rises as the founder retires

    4:41 p.m. Dec. 18, 2020

    - Seeking Alpha

  3. Ionis surges after Cowen upgrade

    3:56 p.m. Dec. 15, 2020

    - Seeking Alpha

  4. Needham Issues a Buy Rating on Ionis Pharmaceuticals (IONS)

    12:55 p.m. Dec. 8, 2020

    - SmarterAnalyst

  5. Seeking Alpha Catalyst Watch

    3:30 p.m. Dec. 4, 2020

    - Seeking Alpha

  6. Pfizer: A 'New' Growth Foundation In Genomic Medicine

    12:12 p.m. Nov. 30, 2020

    - Seeking Alpha

  7. Genomic Medicine: Slowly Moving To All At Once

    8:50 p.m. Nov. 16, 2020

    - Seeking Alpha

  8. Ionis (IONS) Misses Estimates for Q3 Earnings and Sales

    9:57 a.m. Nov. 5, 2020

    - Zacks.com

  9. Loading more headlines...
/news/pressrelease/company/us/ions

Press Releases on IONS

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.